Stenting and Dilation Devices Market Size, Share & Trends Analysis | Global | 2025-2032 | Includes: Esophageal Stents, Duodenal Stents, Colonic Stents, and 3 more

Description

List of Tables

The global stenting and dilation device market was valued at approximately $689 million in 2025. The market is projected to grow at a compound annual growth rate (CAGR) of 3%, reaching more than $847 million by 2031.

This report covers esophageal stents and dilation balloons, duodenal stents and dilation balloons, and colonic stents and dilation balloons. Biliary and pancreatic stents and dilation balloons are analyzed separately under the endoscopic retrograde cholangiopancreatography (ERCP) market chapter.

The report quantifies units, average selling prices (ASPs), market values, growth rates, and company shares, and it provides a detailed analysis of market drivers and limiters, mergers and acquisitions, and technology trends. It includes historical data from 2021 to 2024 and forecasts to 2031.

The scope reflects how technological innovation, expanding clinical indications, and material advancements continue to shape product adoption and performance across gastrointestinal (GI) procedures worldwide.

Market Overview

Stenting and dilation devices are central to the management of strictures and obstructions within the gastrointestinal tract. These devices are used to restore luminal patency and relieve symptoms in patients with malignant and benign conditions of the esophagus, duodenum, and colon.

In recent years, the market has evolved significantly as physicians adopt less invasive alternatives to surgery. Stenting procedures now represent a primary treatment option in cases where surgical intervention once dominated. The growing preference for endoscopic solutions aligns with the medical community's broader shift toward shorter hospital stays, lower complication risks, and reduced recovery times.

The transition from bare-metal to fully covered self-expanding metal stents (SEMS) underscores a clear trend toward improved safety and retrievability. Developments in bioabsorbable and drug-eluting stents are expanding the therapeutic landscape, with early clinical evidence showing better patient tolerance and reduced restenosis rates.

Meanwhile, dilation balloons continue to gain traction as an adjunct or standalone therapy for stricture management. Multi-stage balloon systems that enable progressive dilation through a single device are improving procedural efficiency and outcomes, supporting stronger ASPs and contributing to market value growth.

Overall, the global stenting and dilation market reflects the convergence of clinical efficacy, material innovation, and cost-effectiveness, positioning these technologies as key enablers of minimally invasive care.

Market Drivers

Expansion of Uses and Indications

Physician adoption of stents and dilation balloons has expanded beyond traditional oncologic applications into new therapeutic areas, including benign esophageal strictures, bariatric complications, and post-surgical leaks. Clinical studies have demonstrated that duodenal stenting is often less invasive and more cost-effective than surgical alternatives for managing obstructive strictures, supporting its broader use in both palliative and curative settings.

As healthcare systems prioritize value-based outcomes, stenting has become a preferred treatment pathway for cost-sensitive patients and payers. Likewise, the adoption of esophageal dilation balloons continues to rise as awareness grows around reflux-related disorders and the benefits of reinforcing weakened tissue without open surgery.

These trends are expanding procedural volumes globally, particularly in regions where healthcare systems are strengthening endoscopic capabilities.

New Technologies

Innovation is a primary growth driver for the global stenting and dilation market. The introduction of fully covered metal stents has improved removal capability, reduced tissue ingrowth, and lowered complication rates. By 2025, bioabsorbable and drug-eluting stents had moved from pilot studies into commercial availability, with early adopters reporting improved patient outcomes.

Material science continues to advance, with lighter and stronger alloys and polymer coatings enhancing device flexibility and radial force while minimizing migration. These developments are improving procedural success and contributing to better long-term patency rates, fueling sustained market growth.

Multi-Stage Dilation Balloons

Surgeons increasingly prefer multi-stage dilation balloons over single-stage designs because they allow gradual, controlled dilation of strictures. This method has been clinically shown to reduce tissue trauma and perforation risk while improving lumen expansion consistency.

Although multi-stage systems carry higher ASPs than conventional balloons, their superior safety and effectiveness are driving adoption across major markets. As these devices become standard practice, they are expected to elevate overall market value and support the growth of the premium product segment.

Market Limiters

Despite promising growth, several factors continue to constrain broader market expansion.

Cost Pressures and Reimbursement Challenges

Reimbursement structures vary widely across regions, and in some developing markets, coverage for GI stenting procedures remains limited. Hospitals facing budget constraints often prioritize reusable or lower-cost options, reducing ASP growth potential.

Clinical Training and Access to Equipment

In lower-resource regions, access to high-quality endoscopy suites and trained personnel remains inconsistent. The learning curve for complex stenting procedures can limit adoption, particularly for emerging technologies like bioabsorbable stents.

Device Migration and Complications

While material improvements have reduced complications, stent migration and occlusion remain clinical concerns. These issues can lead to repeat procedures, increasing total cost of care and influencing product preference toward more established designs.

Overall, market growth depends heavily on training, evidence generation, and reimbursement expansion, particularly in emerging regions.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, and market forecasts

Growth rates, units sold, and average selling prices (ASPs)

Qualitative Coverage

Growth trends, market limiters, and technology advancements

Competitive analysis, mergers and acquisitions

Company profiles and product portfolios

Procedure numbers and technology trends shaping adoption

Time Frame

Base year: 2025
Forecasts: 2025-2032
Historical data: 2022-2024

Data Sources

Primary interviews with gastroenterologists and industry experts, regulatory and hospital procurement data, import and export data, and the iData Research internal database.

Method Note

Market revenues are modeled from units multiplied by ASP, validated with procedural data, utilization rates, and replacement assumptions for each stent and balloon category.

Markets Covered and Segmentation

Stenting & Dilation Device Market - Further Segmented Into:

Esophageal Stent

Duodenal Stent

Colonic Stent

Esophageal Dilation Balloon

Duodenal Dilation Balloon

Colonic Dilation Balloon

Competitive Analysis

The global stenting and dilation device market is moderately concentrated, with a few multinational firms accounting for the majority of global revenue.

Boston Scientific led the market in 2025, holding approximately 50% of total market share. The company's broad endoscopic accessories portfolio enables hospitals to source multiple device categories from a single vendor, reinforcing brand loyalty and simplifying procurement. Boston Scientific's stent technologies are widely recognized for their clinical reliability and global distribution reach.

Cook Medical ranked second in 2025, maintaining a strong presence in dilation balloons and specialized esophageal applications. The company offers three esophageal balloon lines, including Quantum TTC(R) dilation balloons, designed specifically for treating achalasia. Through its focus on this clinical niche, Cook Medical supplies a large proportion of balloons used for esophageal motility disorders worldwide.

Olympus Corporation held the third-largest position, strengthened by its acquisition of Taewoong Medical Co., Ltd., a South Korean manufacturer of GI metallic stents. This acquisition expanded Olympus's product range and geographic reach, especially across Europe. The company's Niti-S(TM) and COMVI(TM) product lines include fully and partially covered stents for esophageal, duodenal, and colonic use. Olympus's competitive pricing and partnerships with national distributors across 25 countries make its portfolio appealing to cost-conscious healthcare systems.

Other participants include regional manufacturers active in limited geographies or product types. The concentrated nature of the market encourages continued investment in quality, evidence generation, and product differentiation, while raising the entry barrier for new competitors.

Technology and Practice Trends

Fully covered and drug-eluting stents are replacing older bare-metal designs due to improved removability and reduced tissue ingrowth.

Bioabsorbable stent technologies are in early adoption stages, showing promise for temporary indications.

Multi-stage dilation balloons are becoming standard for benign strictures due to superior safety outcomes.

Improved delivery systems now allow more precise placement, reducing procedural time and fluoroscopy exposure.

Material innovation, including hybrid polymer-metal frameworks, is enhancing radial force while minimizing patient discomfort.

Clinical focus is shifting toward evidence-based selection of stent type and coverage, supported by international guidelines that standardize practice patterns.

Geography

This edition provides global coverage, including detailed breakdowns for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global stenting and dilation device market, and which categories are expected to gain share through 2031?

How are technological innovations, including bioabsorbable materials and drug-eluting designs, reshaping product performance and clinical decision-making?

What are the economic and procedural trends influencing adoption across regions, and how do reimbursement models affect market potential?

How are training access, material advancements, and patient safety outcomes influencing hospital purchasing decisions?

Which product types and manufacturers are most strongly positioned to benefit from the ongoing shift toward minimally invasive GI therapies?

How can suppliers leverage multi-stage balloon innovations and next-generation stent designs to strengthen their market position and pricing strategy?

The Global Stenting & Dilation Device Market Report from iData Research answers these questions with procedure-aware modeling, company share analysis, and price benchmarking. Use it to quantify demand, plan portfolio strategy, guide pricing decisions, and identify the next phase of global growth opportunities.

Product Code: iDATA_GLGI26_SD_MC

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Stenting & Dilation Market

6.1 Executive Summary
- 6.1.1 Global Stenting & Dilation Market Overview
- 6.1.2 Competitive Analysis
- 6.1.3 Procedure Segmentation
- 6.1.4 Market Segmentation
- 6.1.5 Regions Included
6.2 Introduction
6.3 Procedure Numbers
- 6.3.1 Stenting Procedures
  - 6.3.1.1 Esophageal Stenting Procedures
  - 6.3.1.2 Duodenal Stenting Procedures
  - 6.3.1.3 Colonic Stenting Procedures
- 6.3.2 Dilation Procedures
  - 6.3.2.1 Esophageal Dilation Procedures
  - 6.3.2.2 Duodenal Dilation Procedures
  - 6.3.2.3 Colonic Dilation Procedures
6.4 Market Overview
- 6.4.1 By Segment
- 6.4.2 By Region
6.5 Market Analysis And Forecast
- 6.5.1 Total Stenting & Dilation Market
- 6.5.2 Esophageal Stent Market
  - 6.5.2.1 Covered-Metal Esophageal Stent Market
  - 6.5.2.2 Bare-Metal Esophageal Stent Market
  - 6.5.2.3 Plastic Esophageal Stent Market
- 6.5.3 Duodenal Stent Market
- 6.5.4 Colonic Stent Market
- 6.5.5 Esophageal Dilation Balloon Market
- 6.5.6 Duodenal Dilation Balloon Market
- 6.5.7 Colonic Dilation Balloon Market
6.6 Drivers And Limiters
- 6.6.1 Market Drivers
- 6.6.2 Market Limiters
6.7 Competitive Market Share Analysis

Abbreviations